Abstract:Background: When a genetic mutation is identified in a family member (proband), internationally, it is usually the proband's or another responsible family member's role to disclose the information to at-risk relatives. However, both active and passive non-disclosure in families occurs: choosing not to communicate the information or failing to communicate the information despite intention to do so, respectively. The ethical obligations to prevent harm to at-risk relatives and promote the duty of care by genetic health professionals (GHPs) is in conflict with Privacy laws and professional regulations that prohibits disclosure of information to a third party without the consent of the proband (duty of confidentiality). In New South Wales (NSW), Australia, amendments to Privacy legislation permits such disclosure to living genetic relatives with the process defined under guidelines although there is no legal duty to warn. This study assessed NSW GHP's awareness and experience of the legislation and guidelines. Methods: An online survey collected demographics; theoretical knowledge; clinical scenarios to assess application knowledge; attitudes; confidence; experience with active non-disclosure. A link to correct answers was provided after completion. Knowledge scores above the median for non-parametric data or above the mean for parametric data were classified as 'good' or 'poor'. Chi square tests assessed associations between confidence and knowledge scores. Results: While many of the 37 participants reported reading the guidelines, there was limited awareness of their scope and clinical application; that there is no legal duty to warn; and that the threat does not need to be imminent to warrant disclosure. No association between confidence and 'good' theoretical or applied clinical knowledge was identified. Uncertainty of their professional responsibility was identified and in the several case examples of active non-disclosure that were reported this uncertainty reflected the need for further understanding of the guidelines in regard to the processes required before disclosure was initiated. Conclusions: There is a need for further education and training about the guidelines associated with the legislation that would be relevant to support disclosure. The findings may inform future strategies to support introduction of policy changes in other jurisdictions where similar regulatory regimes are introduced.

Privacy protection and public goods: building a genetic database for health research in Newfoundland and Labrador

Enabling responsible public genomics

A nation's genes for a cure to cancer: evolving ethical, social and legal issues regarding population genetic databases

Trends in ethical and legal frameworks for the use of human biobanks

Beliefs and attitudes towards participating in genetic research - a population based cross-sectional study

Towards a trusted genomics repository: Identifying commercialisation fears and preferred forms of governance across segments of the community

Balancing the local and the universal in maintaining ethical access to a genomics biobank

Genetic Research: The Role of Citizens, Public Health and International Stakeholders

Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision Makers

The Australian joint inquiry into the Protection of Human Genetic Information

Policy Recommendations for Addressing Privacy Challenges Associated with Cell-Based Research and Interventions.

"Protection for the public, better use of resources and clearer lines": Interviews with genetic counselors and their colleagues on the need for regulation in Quebec

Privacy-Preserving Collaborative Genomic Research: A Real-Life Deployment and Vision

Ethical and social implications of public–private partnerships in the context of genomic/big health data collection

What Legal Frameworks Should Govern Use of Genetic Test Results by Private Health Insurers in New Zealand?

Global Public Perceptions of Genomic Data Sharing: What Shapes the Willingness to Donate DNA and Health Data?

Secondary use of genomic data: patients' decisions at point of testing and perspectives to inform international data sharing

No person left behind: Mapping the health policy landscape for genomics research in the Caribbean

Genetic discrimination views in online discussion forums: Perspectives from Canadian forumites

Privacy in the Genomic Era

Disclosure to genetic relatives without consent - Australian genetic professionals' awareness of the health privacy law